Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Becton Dickinson and Company (BDX)

Becton Dickinson and Company (BDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 66,263,928
  • Shares Outstanding, K 290,008
  • Annual Sales, $ 20,178 M
  • Annual Income, $ 1,705 M
  • EBIT $ 2,398 M
  • EBITDA $ 4,684 M
  • 60-Month Beta 0.41
  • Price/Sales 3.28
  • Price/Cash Flow 10.79
  • Price/Book 2.55

Options Overview Details

View History
  • Implied Volatility 18.60% ( +0.28%)
  • Historical Volatility 14.85%
  • IV Percentile 35%
  • IV Rank 24.27%
  • IV High 28.78% on 08/05/24
  • IV Low 15.34% on 11/26/24
  • Put/Call Vol Ratio 0.31
  • Today's Volume 232
  • Volume Avg (30-Day) 1,168
  • Put/Call OI Ratio 0.86
  • Today's Open Interest 26,121
  • Open Int (30-Day) 22,383

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 17 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate 2.98
  • Number of Estimates 10
  • High Estimate 3.00
  • Low Estimate 2.93
  • Prior Year 2.68
  • Growth Rate Est. (year over year) +11.19%

Price Performance

See More
Period Period Low Period High Performance
1-Month
218.84 +4.41%
on 12/11/24
231.74 -1.40%
on 12/16/24
+6.51 (+2.93%)
since 11/27/24
3-Month
218.84 +4.41%
on 12/11/24
244.50 -6.55%
on 10/15/24
-13.02 (-5.39%)
since 09/27/24
52-Week
218.75 +4.45%
on 07/10/24
249.89 -8.56%
on 01/09/24
-14.01 (-5.78%)
since 12/27/23

Most Recent Stories

More News
4 Highest-Rated Dividend Aristocrats To Buy Now

These three highly-rated companies offer a combination of growth and at least 25 years of increasing dividends.

KO : 62.45 (-0.19%)
BDX : 228.49 (+0.16%)
BDX : 228.49 (+0.16%)
SPGI : 501.80 (-0.59%)
WMT : 91.66 (-1.22%)
How Is Baxter International's Stock Performance Compared to Other Medical Devices Stocks?

Baxter International has lagged behind its peers in the medical devices industry over the past three months, and analysts are cautious about the stock's prospects.

BDX : 228.49 (+0.16%)
BAX : 29.20 (-0.34%)
IHI : 59.29 (-0.45%)
Top 3 Dividend Kings Trading at a Deep Discount Today

These three highly-rated dividend growth stocks are trading cheap. Find out if now is the time to buy.

KO : 62.45 (-0.19%)
BDX : 228.49 (+0.16%)
TNC : 80.78 (-0.91%)
3 Highly-Rated Dividend Stocks To Buy on the Dip

Discover 3 top income stocks with low payout ratios, strong buy ratings, and long-term growth potential.

$SPX : 5,970.84 (-1.11%)
CI : 278.71 (-1.02%)
BDX : 228.49 (+0.16%)
ELV : 371.07 (-0.69%)
Is Becton, Dickinson and Company Stock Underperforming the Dow?

Becton, Dickinson and Company have underperformed the Dow Jones Industrials Average over the past year, yet Wall Street analysts maintain a bullish outlook on the stock’s prospects.

EW : 75.65 (-0.36%)
BDX : 228.49 (+0.16%)
$DOWI : 42,992.21 (-0.77%)
Insider Sale: EVP and President of $BDX (BDX) Sells 638 Shares

Roland Goette, the EVP and President of $BDX ($BDX), sold 638 shares of the company on 12-09-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 4.3% of their...

BDX : 228.49 (+0.16%)
Insider Sale: EVP and President of $BDX (BDX) Sells 4,483 Shares

Roland Goette, the EVP and President of $BDX ($BDX), sold 4,483 shares of the company on 12-06-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 15.6% of their...

BDX : 228.49 (+0.16%)
Insider Sale: EVP and Chief ISC Officer of $BDX (BDX) Sells 1,500 Shares

David Shan, the EVP and Chief ISC Officer of $BDX ($BDX), sold 1,500 shares of the company on 12-05-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 19.3%...

BDX : 228.49 (+0.16%)
Becton, Dickinson and Company Stock Outlook: Is Wall Street Bullish or Bearish?

Despite Becton, Dickinson and Company’s underperformance relative to the broader market over the past year, Wall Street analysts remain bullish about the stock’s prospects.

XLV : 138.95 (-0.47%)
$SPX : 5,970.84 (-1.11%)
BDX : 228.49 (+0.16%)
Hologic Post Q4 Earnings Miss: Time to Buy, Hold or Sell the Stock?

On Monday, Hologic HOLX released its fiscal 2024 fourth-quarter financial report after the closing bell, with revenues slightly surpassing the consensus mark. The bottom line fell short of estimates...

HOLX : 72.60 (-0.17%)
BDX : 228.49 (+0.16%)
QGEN : 44.99 (-0.04%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Becton, Dickinson and Company, is a medical technology company engaged principally in the development, manufacture and sale of medical devices, instrument systems and reagents. BD's operations consisted of three business segments: BD Medical, BD Diagnostics and BD Biosciences. The company's organizational...

See More

Key Turning Points

3rd Resistance Point 233.52
2nd Resistance Point 231.80
1st Resistance Point 230.15
Last Price 228.49
1st Support Level 226.78
2nd Support Level 225.06
3rd Support Level 223.41

See More

52-Week High 249.89
Fibonacci 61.8% 237.99
Fibonacci 50% 234.32
Fibonacci 38.2% 230.65
Last Price 228.49
52-Week Low 218.75

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar